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The behavioural variant of frontotemporal dementia is a clinical syndrome 
characterised by changes in behaviour, cognition and functional ability. Although 
atrophy in frontal and temporal regions would appear to be a defining feature, 
neuroimaging studies have identified volumetric differences distributed across large 
parts of the cortex, giving rise to a classification into distinct neuroanatomical sub-
types. Here, we extended these neuroimaging studies to examine how distributed 
patterns of cortical atrophy map onto brain network hubs. We used baseline structural 
magnetic resonance imaging data collected from 213 behavioural variant of 
frontotemporal dementia patients meeting consensus diagnostic criteria and having 
definite evidence of frontal and/or temporal lobe atrophy from a global clinical trial 
conducted in 70 sites in Canada, United States of America, Australia, Asia and Europe. 
These were compared with data from 244 healthy elderly subjects from a well-
characterised cohort study. We have used statistical methods of hierarchical 
agglomerative clustering of 68 regional cortical and subcortical volumes (34 in each 
hemisphere) to determine the reproducibility of previously described neuroanatomical 
subtypes in a global study. We have also attempted to link the structural findings to 
clinical features defined systematically using well-validated clinical scales 
(Addenbrooke’s Cognitive Examination Revised, the Mini-Mental Status 
Examination, the Frontotemporal Dementia Rating Scale and the Functional 
Assessment Questionnaire) and subscales derived from them. Whilst we can confirm 
that the subtypes are robust, they have limited value in explaining the clinical 
heterogeneity of the syndrome. We have found that a common pattern of degeneration 
affecting a small number of subcortical, limbic and frontal nodes within highly 
connected networks (most previously identified as rich club members or functional 
binding nodes) is shared by all the anatomical subtypes. Degeneration in these core 
regions is correlated with cognitive and functional impairment, but less so with 
behavioural impairment. These findings suggest that degeneration in highly connected 
basal, limbic and frontal networks is a core feature of the behavioural variant of 
frontotemporal dementia phenotype irrespective of neuroanatomical and clinical 
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heterogeneity, and may underly the impairment of integration in cognition, function 
and behaviour responsible for the loss of insight that characterises the syndrome.
Keywords: behavioural variant frontotemporal dementia, brain networks, rich club, 
neurodegeneration, anatomical subtypes
Abbreviations: ABC36 = Aberdeen 1936 Birth Cohort; ACE-R = ; AD = 
Alzheimer’s disease; bvFTD = behavioural variant of frontotemporal dementia; eTIV 
= estimated total intracranial volume; FAQ = functional activities questionnaire; FD 
= frontal-dominant; FRS = frontotemporal dementia rating scale; FTD = 
frontotemporal dementia; FTD = frontotemporal dementia; FTP = 
frontotemporoparietal; FP = frontoparietal; GLM = general linear model; MMSE = 
mini-mental state examination; MNI = Montreal Neurological Institute; ROI = region 
of interest; SL = sub-lobar; TD = temporal-dominant; VBM = voxel-based 
morphometric.
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Frontotemporal dementia (FTD) is a heterogeneous disorder with distinct clinical 
phenotypes associated with multiple neuropathologic entities (Olney et al.,,  2017). The 
core FTD disorders are behavioural variant frontotemporal dementia (bvFTD), semantic 
variant primary progressive aphasia, and non-fluent variant primary progressive aphasia, 
but there are other disorders within the FTD spectrum that include frontotemporal dementia 
with motor neurone disease, progressive supranuclear palsy and corticobasal syndrome. 
Most cases of FTD have underlying tau, transactive response DNA-binding protein-43 
(TDP-43) or fused in sarcoma, Ewing’s sarcoma or TATA-binding protein associated 
factor 15 (collectively known as the FET protein family) neuropathology (Mackenzie and 
Neumann 2016).
bvFTD is a clinical syndrome characterised by insidious onset and progressive 
deterioration in behaviour, cognition and functional ability, the core symptoms being: 
disinhibition, apathy, lack of empathy, compulsions, hyperorality and impairment of 
executive function (Rascovsky et al.,, 2011). Recently, higher levels of socially 
inappropriate behaviour and criminality in bvFTD compared with Alzheimer’s disease 
(Liljegren et al.,, 2019) have been recognised, due to a dissociation between factual and 
evaluative understanding of actions and their consequences (Mendez, 2010; Sfera et al.,, 
2014). Some patients may display the core clinical symptoms as a phenocopy syndrome 
that is not associated with brain atrophy (Devenney et al.,, 2018; Kipps et al.,. 2009; 
Valente et al.,, 2019). The revised diagnostic criteria for bvFTD therefore additionally 
require imaging evidence of a frontotemporal abnormality for a diagnosis of probable 
bvFTD. 
Although atrophy in frontal and temporal regions would appear to be a defining 
feature, neuroimaging studies have identified volumetric differences distributed across 
large parts of the cortex, giving rise to a classification into distinct neuroanatomical sub-
types (Josephs et al., 2009; Ranasinghe et al., 2016; Rohrer et al., 2011; Whitwell et al., 
2009, 2013). Different patterns of atrophy have also been associated with different types 
of FTD pathology and mutations (Perry et al., 2017; Rohrer et al., 2009). However, all 
pathological subgroups appear to share atrophy in the anterior cingulate, fronto-insula 
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region, striatum, and amygdala. Studies of genetic frontotemporal dementia have also 
shown that structural brain changes occur in insula at least ten years before expected 
symptom onset (Rohrer et al., 2015). These vulnerable connected regions, which are 
affected early in bvFTD, are part of  what has been termed the   ‘salience’ network which 
is thought to be responsible for processing of behaviourally salient stimuli in the normal 
brain (Perry et al., 2017; Seeley, Menon, et al., 2007; Seeley et al., 2008, 2009). However, 
resting state network functional abnormalities may also extend to the default mode, fronto-
parietal and semantic appraisal networks resulting in other symptoms affecting attention, 
working memory and semantics (Filippi et al., 2013; Ranasinghe et al., 2016). Recent 
evidence shows that the overlapping regions of resting state networks are organised into 
highly interconnected brain network hubs. Brain hubs are implicated in many types of 
dementia because of the role they play in integrating brain functions (van den Heuvel & 
Sporns, 2013). Given the highly heterogeneous neuroanatomical sub-types in bvFTD, it is 
interesting to ask whether the anatomical heterogeneity involves these central brain 
regions, or whether atrophy in core regions is a common feature independent of cortical 
heterogeneity. We have previously reported the results of a voxel-based morphometric 
(VBM) comparison of baseline MRI scans of patients in a large randomised controlled 
clinical trial in bvFTD (TRx-237-007, NCT01626378) with those randomised to a 
comparable study of mild AD (TRx-237-005). This showed that the bvFTD group was 
clearly distinguishable from the mild AD group with a similar overall level of cognitive 
impairment (Shiells et al., 2020; Vuksanović et al., 2019). As expected, the bvFTD patients 
had significantly more atrophy in frontal cortex and anterior temporal cortex, and 
significantly less atrophy in hippocampus, middle temporal gyrus, cuneus and insula. 
We undertook the present study to determine how the apparent cortical heterogeneity 
of bvFTD subtypes relates to atrophy in central brain hubs and whether the subtypes are 
associated with distinctive clinical profiles. To address these question, we have used 
baseline structural magnetic resonance imaging (MRI) data collected from 213 bvFTD 
patients meeting consensus diagnostic criteria (Rascovsky et al., 2011) and having definite 
evidence of frontal and/or temporal lobe atrophy (Kipps et al., 2008) and compared this 
with data from 244 healthy elderly subjects from a well-characterised cohort study (Murray 
et al., 2011). In addition, the availability of systematically collected clinical baseline scores 
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using validated cognitive and functional scales provided the opportunity to determine how 
neuroanatomical subtypes and atrophy in brain networks relate to distinctive clinical 
profiles. Whilst we confirm the existence of the subtypes, we show that they have limited 
ability to explain clinical heterogeneity in bvFTD. On the other hand, we report that the 
subtypes share a common pattern of degeneration affecting a small number of highly 
connected nodes which have a subcortical, limbic and frontal distribution. Degeneration in 




Study TRx-237-007 was designed as a 52-week Phase three, randomised, controlled, 
double-blind, parallel-group trial conducted at 70 sites in Canada, United States of 
America, Australia, Asia and Europe. Eligible patients had to be younger than 80 years of 
age with a diagnosis of bvFTD according to criteria revised by the International bvFTD 
Criteria Consortium (Rascovsky et al., 2011), with mini-mental status examination 
(MMSE; (Folstein et al., 1975)) score greater than or equal to 20 at screening. There was 
an additional requirement that patients had to meet the criterion of having definite brain 
atrophy in frontal and/or temporal lobes scoring two or more on a scale proposed by Kipps 
(Kipps et al., 2008). Concomitant use of acetylcholinesterase inhibitors or memantine (or 
both) was permitted provided this was at a stable dose for at least 18 weeks before 
randomisation. Concomitant use of serotonergic antidepressant, antipsychotic (except 
clozapine or olanzapine) and sedative medications was also permitted at stable doses where 
clinically feasible. Each patient had one or more study partners participate with them in the 
trial as informants. Patients were excluded from the study if they had a significant CNS 
disorder other than bvFTD. A detailed list of inclusion and exclusion criteria in the protocol 
is available in the Supplementary Materials in Shiells et al. (Shiells et al., 2020). As 
reported in that paper, the mean (SD) time since diagnosis of bvFTD was 1.9 (2.4) years, 
the MMSE severity at baseline was 24.6 (3.1) and 82.3% of the cases were at Kipps MRI 
severity stages 2 or 3. Of the 7/159 cases in whom mutations in coding regions were 
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identified, 6 involved the tau gene and one implicated TDP-43. Baseline MRI scans were 
evaluated by a single independent neuroradiologist out of a pool of trained 
neuroradiologists to determine eligibility (RadMD, NY).
 In addition, MRI scans were obtained from 244 age-matched healthy controls from 
the well characterised Aberdeen 1936 Birth Cohort (ABC36) brain imaging database held 
in the Aberdeen Biomedical Imaging Centre at the University of Aberdeen. The ABC36 
project has been described elsewhere (Murray et al., 2011; Whalley et al., 2011).  
Demographics and clinical characteristics of the study groups are given in Table 1.
MRI data collection 
The acquisition protocol was standardised across sites using 1.5T and 3T scanners 
manufactured by General Electric, Philips or Siemens. All data were centrally collected, 
quality-controlled and analysed by the imaging core laboratory (Bioclinica). MRI data 
acquisition included a 3D sagittal T1-weighted sequence which we used in our analysis 
here.  3DT1 images were acquired using a 3D MPRAGE sequence (Siemens) or the 
specific manufacturer equivalent sequence (General Electric 3D IR-prepped Fast SPGR, 
Philips 3D TFE), covering the whole brain with a resolution of 1.25×1.25×1.2 mm3. 
FreeSurfer version 5.3.0 (http://freesurfer.net/) was used to extract regional volumes 
for the clustering analysis. FreeSurfer automated segmentation parcelates the brain into  76 
regions according to the Desikan-Killiany Atlas (Desikan et al., 2006). For the purpose of 
this study, we selected 68 regional volumes (34 from each hemisphere) of the frontal, 
temporal or parietal lobe and additional sub-lobar regions (limbic lobes, basal ganglia, 
amygdala and thalamus) previously identified as locations of atrophy in bvFTD and/or as 
anatomical correlates of clinical symptoms. A full list of regions is given in the 
Supplementary Table 1.
Hierarchical agglomerative clustering, implemented in SPSS v.23.0, was used to 
classify differences/similarities in the 68 regional volumes. The bottom-up hierarchical 
agglomerative clustering is based on similarities and linkages between data points (subject-
wise region of interest [ROI] volumes on MRI), with successive agglomeration of pairs of 
clusters until all clusters are merged into a single cluster containing all subjects. Similarity 
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was measured by Euclidean distance between pairs of data points and linkage was 
measured by Ward’s linkage method (Ward, 1963).  It is possible to classify bvFTD groups 
into either three or four clusters depending on the cluster distance. We used the 4-group 
clustering in further analyses for consistency with previous studies (Ranasinghe et al., 
2016; Whitwell et al., 2009). Each of these groups was compared to the healthy elderly 
subject group using voxel based morphometry (VBM).
The VBM processing procedure employed for this study followed the steps described 
in by Ashburner (Ashburner, 2015). In short, the images were first segmented into grey 
matter, white matter and cerebrospinal fluid mask images (Ashburner, 2015; Ashburner 
and Friston, 2005). Each class of the segmented images were then warped together and 
non-linearly registered so that they matched each other (Ashburner and Friston, 2011). A 
custom template was created from a data set of all participants in the study. Finally, images 
were normalized to the Montreal Neurological Institute (MNI) space and smoothed with a 
Gaussian kernel (8 mm FWHM). Each group identified by the clustering technique was 
compared to the healthy control group. Regions showing atrophy in the bvFTD group were 
identified from the MNI coordinates of the voxels within the areas that were significantly 
different using maximum difference t-test statistics. All image processing steps and 
statistical analysis were implemented in the Statistical Parametric Mapping (SPM12) 
software package available at http://www.fil.ion.ucl.ac.uk/spm/. The t-tests were 
performed on each pair of voxels/volumes corrected for age, gender and either estimated 
total intracranial volume (Whitwell et al., 2009) or total brain volume (Bigler and Tate, 
2001) to correct for global atrophy/severity. Recording sites were included in the model as 
a random covariate. To correct for the false discoveries of significant differences due to 
multiple tests, the t-test statistics were corrected at the significance level p < 0.05 using the 
family-wise-error correction available in the VBM statistical package. Figure 1 shows 
overall procedure: generation of 68 regions of interest (ROIs) in Free Surfer, classification 
of bvFTD subjects into four clusters using hierarchical clustering and cluster-wise 
comparisons with healthy control using VBM to determine regions affected by 
neurodegeneration.  
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Baseline clinical assessments included the Addenbrooke’s Cognitive Examination 
Revised (ACE-R) (Mioshi et al., 2006), the Mini-Mental State Examination (Folstein et 
al., 1975), the Frontotemporal Dementia Rating Scale (FRS) (Mioshi et al., 2010) and the 
Functional Assessment Questionnaire (FAQ)(Pfeffer et al., 1982). The bvFTD subtypes 
were compared using these scales and using subscales derived from the ACE-R and FRS 
prior to identification of the bvFTD subtypes. A total of 18 subscales were created: 11 
cognitive subscales (from the ACE-R) and seven behavioural subscales (from the FRS). 
The FAQ scale was used in its entirety as an independent measure of activities of daily 
living. The primary scales and derived subscales are described in greater detail in the 
Supplementary Information.
Statistical analyses
Statistical analyses were performed using SPSS v.23.0, employing paired samples t-
tests to compare males and females in Table 1. One-way ANOVA was used to test 
differences between bvFTD subtypes in cognitive and behavioural sub-scores given in 
Table 2. A significance level of p < 0.05 was used.  
In order to generate a summary variable accounting for the multiple regional volumes 
affected by neurodegeneration, we employed a post hoc principal component analysis to 
reduce the volume measurements into a manageable number of factors. We examined 
clinical-anatomical correlations using general linear models (GLM). In these we tested for 
associations between clinical measures and the first volumetric summary variable 
accounting for 40% of the variance. The models used included adjustments for known and 
potential confounders: age, sex, head size and anatomical subtype.
Data Availability
Data supporting the findings of this study are available from the corresponding author, 
upon reasonable request. 
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Demographic and clinical features of the populations studied
A total of 213 bvFTD patients of 220 randomised to the trial were included in the 
present study based on baseline MRI scan quality and the complete clinical data required 
for the present study at baseline. Baseline demographic and clinical data are provided in 
Table 1. Mean (± SD) age was 63 ± 7 years for both males (136) and females (77). Total 
years in education were 15.4 ± 0.5, with no difference between males and females. The 
estimated total intracranial volume (eTIV) was significantly larger in males (1600 ± 220 
cm3) than in females (1400 ± 150 cm3), although there was no difference in brain 
parenchymal fraction (BF, 0.67 ± 0.06). The MMSE score was significantly higher in males 
(25.4 ± 3.5) than in females (22.9 ± 4.0), as was the total ACE-R score (males: 72 ± 16; 
females: 62 ± 14). Males performed better on most of the ACE-R subscales apart from 
phonemics, language structure, episodic memory and perceptual abilities. By contrast, 
there was no overall difference on either the FRS or the FAQ score between males and 
females. The only FRS subscales showing a gender difference were ADL (where males 
performed better) and disinhibition (where males performed worse). There were no 
demographic differences between patients prescribed symptomatic treatments approved for 
AD (but not bvFTD) and those not receiving these treatments.
There were 133 males and 111 females in the healthy elderly group. There were no 
sex differences in age, years of education or MMSE score. The healthy elderly group was 
significantly older (69 ± 2 years), had less education (11 ± 2 years), and had a higher 
MMSE score (28.9 ± 1.2) than the bvFTD group. 
 Classification of bvFTD subjects by agglomerative clustering based on 
regional brain volumes
We applied a hierarchical agglomerative clustering algorithm using Euclidean 
distance and Ward linkage to provide measures of differences/similarities in the 68 regional 
volumes of the Desikan-Killiany Atlas (Desikan et al., 2006). The tree/dendrogram is 
shown in Supplementary Fig. 1. It is possible to classify bvFTD groups into either three or 
four clusters depending on the cluster distance. We used the 4-group clustering in further 
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analyses for consistency with previous studies (Ranasinghe et al., 2016; Whitwell et al., 
2009). Each of these groups was then treated as a single group and compared to the healthy 
elderly subject group using VBM. Figure 2 shows the 3D surface rendering of the voxel-
wise differences between each of the bvFTD groups and the healthy elderly group after 
correction for total intra-cranial volume.  A similar result was found when the correction 
was based on estimated brain volume (Supplementary Fig. 3). Following Whitwell and 
colleagues (Whitwell et al., 2013), we designated the four anatomical sub-types:  
fronto/temporo/parietal (FTP), frontal-dominant (FD), temporal-dominant (TD) and sub-
lobar (SL). The differences in cortical atrophy across bvFTD subtypes are shown in Figure 
3. 
Degeneration of central basal and limbic nodes as a core feature of bvFTD
Having confirmed the classification of the bvFTD subtypes based on distinct patterns 
of cortical atrophy, we determined how these are linked to atrophy in subcortical and limbic 
regions (Supplementary Fig. 3 and Table 2). As shown in Tables 2 and 3, we found that it 
is possible to distinguish regions that are common to the four subtypes from those that are 
not. The limbic structures found to be common to all subtypes in terms of atrophy included 
anterior cingulate gyrus, hippocampal and parahippocampal gyri, insula and temporal pole 
(superior temporal gyrus). The subcortical grey nuclei affected in all subtypes included 
amygdala, caudate nucleus, pallidum and thalamus. The cortical regions common to the 
subtypes were the orbital surface areas of the frontal cortex (inferior frontal gyrus, olfactory 
cortex and gyrus rectus) and the medial surface areas of the frontal cortex (superior frontal 
gyrus and supplementary motor area).  Only the middle temporal gyrus of the temporal 
lobe was shared between the subtypes. In all cases, the involvement of the common regions 
was bilateral. 
A striking feature of the regions of atrophy shared across subtypes was that all have 
been identified previously as either members of the rich club (van den Heuvel et al., 2012) 
or functional binding nodes (Deco et al., 2017), or as regions having higher than average 
connectivity. As shown in Supplementary Fig. 3 and in Table 2, the rich club members 
identified as undergoing atrophy in all four bvFTD sub-types were superior frontal gyrus, 
thalamus, pallidum, putamen and hippocampus. The functional ‘binding’ regions (Deco et 
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al., 2017) common to the four subtypes include anterior cingulate and insula. In addition, 
parahippocampal gyrus, amygdala and caudate have been identified as highly connected 
nodes. 
By contrast with these subtype-independent regions, the regions listed in Table 3 had 
more limited subtype overlap and were generally unilateral.  Atrophy in the superior 
temporal gyrus was unique to the TD subtype. The FTP subtype showed atrophy in middle 
occipital gyrus and precuneus, and the latter is also seen in the FT subtype.  There was no 
overlap between atrophy and any of the rich club or linker regions that was unique to the 
SL subtype. Degeneration in the superior occipital lobe was unique to the frontal-dominant 
subtype. Atrophy in the superior temporal gyrus, although a functional binding node, was 
unique to the temporal-dominant subtype.
Cognitive, functional and behavioural performance across bvFTD subtypes
The principal cognitive scales, ACE-R and MMSE, showed no significant differences 
according to the bvFTD subtypes (Table 4). By contrast, the functional and behavioural 
scales, FAQ and FRS, showed significant differences (Table 4 and Figure 4), with the FD 
subtype showing greater overall impairment than the others. To examine this further, we 
used FRS subscales to determine whether behavioural elements of the bvFTD syndrome 
could be differentiated according to subtype. As shown in Table 4 and Figure 4, a picture 
like that seen with the full scales emerged, namely that the FD subtype was generally more 
impaired than the others. This could be seen for behavioural symptoms (characterised 
predominantly by lack of appropriate behaviours), apathy/disinterest and disinhibition. The 
only significant exception was that both the FD and TD subtypes were characterised by 
significantly greater impairment on the subscales measuring problematic behaviours than 
the FTL and SL subtypes. Although it was possible to map functional and behavioural 
deficits to specific cortical regions (Supplementary Figs. 7 and 8), these features did not 
discriminate between the bvFTD subtypes identified by structural criteria, apart from 
greater general impairment largely restricted to the FD subtype (see also Supplementary 
Fig. 7). 
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Since overall cognitive impairment did not provide a basis for discriminating between 
the subtypes, we next tested whether cognitive subdomains possessed greater 
discriminatory capacity. Here a more complex picture emerged, as shown in Table 4 and 
Figure 5 (and Supplementary Fig. 8). As expected, the TD subtype was characterised more 
specifically by greater impairment in semantic memory and language semantics, but not in 
episodic memory. The FD subtype was differentiated by more prominent deficits in letter 
fluency. The FTP subtype showed somewhat greater impairment in language phonemics 
and perceptual abilities. There were no cognitive deficits that could be linked more 
specifically to the SL subtype. Although the FTD subtype might appear to be more AD-
like, there were no differences in likelihood of being prescribed symptomatic treatments 
approved for AD.  
A post-hoc examination of the relationship between anatomical core features 
and cognitive, behaviour and functional performance in bvFTD.
It is clear from the foregoing analysis that atrophy patterns in bvFTD can be split into 
those atrophy patterns which are common to all subtypes and those that are associated with 
specific subtypes. Using the core regions, we performed a principal components data 
reduction and found that the first unrotated factor explained 40% of the variance found 
across all core regions. There were significant correlations between this extracted factor 
and cognitive, behaviour and functional scores (Table 5). We next used a general linear 
model (GLM) approach to determine whether these associations depend on unique features 
of the subtype. In this analysis, the cognitive, behaviour and functional scores were 
considered separately as the dependent variable, and sex and subtype were included as 
fixed factors, while age, the summary core factor and head size were included as covariates  
(Table 5).  The GLM analysis showed that the summary core feature drives the association 
with the cognitive scores and the functional activity score. By contrast, the behavioural 
score is associated with the cortical subtype, but not with the summary core feature.
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We have analysed a large clinical cohort of 213 well characterised bvFTD patients 
from a global, multicentre study.  We aimed to examine how common and 
heterogeneous patterns of atrophy account for clinical diversity in this syndrome. 
Whilst confirming the existence of four anatomically distinct subtypes at the cortical 
level, our study has identified sub-lobar and limbic brain atrophy as a core feature of 
bvFTD that is common to the anatomically distinct subtypes that have been described. 
A summary metric based on core region atrophy was found to associate significantly 
with cognitive and functional performance across all subtypes. Conversely, cortical 
heterogeneity was associated with behavioural performance independent of the 
variance explained by the core features. Therefore, the bvFTD syndrome can be 
understood as comprising a core disturbance in highly connected subcortical and limbic 
brain structures that is closely linked to cognitive and functional impairment. 
Common and distinct atrophy patterns
Despite the existence of four anatomically distinct patterns of cortical surface atrophy 
in the population we have analysed, there is a homogenous pattern of atrophy across sub-
cortical and limbic regions that is common to the anatomical subtypes. Of 39 brain regions 
showing atrophy when compared to heathy elderly subjects, 16 regions were found to be 
common to all four subtypes, whereas 23 had selective subtype associations.  Of the 16 
subtype-independent regions of atrophy, 10 have been characterised previously as brain 
hubs, i.e., brain regions with higher than average connectivity. These 10 regions map either 
to  the so-called “rich club” of highly connected nodes (van den Heuvel et al., 2012), to 
highly connected functional binding nodes (Deco et al., 2017) or nodes known to have 
higher than average connectivity in either functional or structural MRI studies (Robinson 
et al., 2012; Ward et al., 2014). These network hubs are central to communication and 
functional integration of the brain and represent potential hotspots for loss of connectivity 
across multiple brain networks (Gollo et al., 2015).   It is known from previous studies that 
the sub-networks of highly connected nodes play an important role in efficient information 
processing between segregated brain areas (Bullmore and Sporns, 2012) and have been 
found to be associated with cognitive performance (Baggio et al., 2015) in healthy brain. 
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Meta-analysis of MRI studies has suggested that the structural brain hubs and their 
connections are highly vulnerable to neurodegeneration  (Crossley et al., 2014; Sha et al., 
2018) although the hubs implicated in bvFTD and AD differ (Daianu et al., 2016). Of the 
23 regions where atrophy is not shared across the subtypes, two were found to be either 
subcortical or limbic, and five are members of the rich club or functional binding group. 
We therefore conclude that degeneration in basal, limbic and frontal networks that have 
high levels of connectivity represents a core feature of the bvFTD syndrome irrespective 
of the distinct cortical subtypes that have been described.
Degeneration of brain network hubs is not unique to bvFTD. It has been noted that 
neurodegeneration targets brain hubs in most of the neurodegenerative disorders (van den 
Heuvel and Sporns, 2019; Stam, 2014; Stam and van Straaten, 2012). As noted above, the 
anatomical sites of atrophy differ between different neurodegenerative disorders. For 
example, the central brain regions affected in AD are more likely to be the medial temporal 
and parietal regions, although thalamus and hippocampus are consistently atrophied in both 
bvFTD and AD. It has been proposed that the increased traffic that hubs are required to 
support may help to explain why these regions have preferentially greater vulnerability to 
neurological disorders in general (van den Heuvel and Sporns, 2013a; de Lange et al., 
2019; Stam, 2014). The vulnerability of the central networks of the human brain to 
neurodegeneration (Stam, 2014) may explain the involvement of some rich club network 
nodes (insula, anterior cingulate, hippocampus, superior temporal pole, pallidum and 
thalamus), but not all (putamen and a number of cortical regions). A high degree of 
connectivity may also make certain regions more vulnerable to prion-like spread of 
pathology arising stochastically in linked subregions. These need not be mutually 
exclusive, since a chronically high level of activity may itself lead to high demands on 
turnover of vulnerable protein systems and predispose to pathological aggregation and 
transmission. 
The core regions identified in this study underpin brain functions relevant to the core 
clinical diagnostic symptoms of bvFTD. The superior frontal gyrus is involved in self-
awareness, cognitive control, emotion regulation, and impulse control. Reduced volumes 
in FTD have been associated with disinhibition (Cajanus et al., 2019) and ADL dysfunction 
(Mioshi et al.,2013). Striatal damage is strongly linked with executive dysfunction, 
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impaired reward-punishment processing, and affective and motivational disturbances 
(O’Callaghan et al., 2014). Striatal atrophy occurs early in bvFTD and has also been 
associated with eating changes. The von Economo neurons (VENs) of the anterior 
cingulate cortex, important for empathy, social awareness, and self-control, are severely 
depleted early in bvFTD (Allman et al., 2010).  VENs from the anterior insula are thought 
important for awareness and together form a network with the striatum and amygdala. The 
amygdala plays a prominent role in mediating decision making, emotional learning and 
behaviour and is often affected early in bvFTD, particularly in cases due to MAPT 
mutations (Bocchetta et al., 2019). The thalamus is a complex modulatory gate. The 
anteroventral and dorsomedial nuclei form part of the dorsolateral prefrontal circuit, related 
to executive function and motor programming, and are also part of the lateral orbitofrontal 
circuit, related to personality and mood regulation (Bocchetta et al., 2018).  Thalamic 
atrophy is particularly prominent with TDP-43 pathology and C9orf72 mutations 
(Bocchetta et al., 2018).
In an admittedly simplified model, Seeley and colleagues have proposed that 
neurodegeneration in bvFTD targets primarily the salience network (Seeley et al. 2012). It 
is hypothesised that this would be responsible for social-emotional-autonomic processing 
(Seeley, Allman, et al., 2007) and affect some other functional brain networks via its 
afferent/efferent interactions. The salience network is closely allied with the ventral 
valuation/context appraisal network also known as the semantic appraisal network (Guo et 
al., 2013), default mode network and task-control or executive network (Cole and 
Schneider, 2007; Possin et al., 2013), all reported as being disrupted in bvFTD. The trans-
modal areas of the default mode and salience network also overlap with the rich club 
network regions (van den Heuvel and Sporns, 2013b; Uddin et al., 2011). Our results 
support the existence of a common underlying pattern of degeneration which is not 
restricted to the salience network. Different cortical subtypes of bvFTD ranging from 
absence of cortical lobar atrophy, to lobe-specific dominance, to multi-lobar atrophy, all 
share degeneration in the basal, limbic and frontal networks we have described.
In our cohort, the fronto-temporo-parietal subtype had the highest frequency (39%) 
and the frontal-dominant (19%), the temporal-dominant (24%) and the sub-lobar subtypes 
(18%) had comparable lower frequencies. Therefore, the syndrome as defined by 
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consensus clinical criteria and by the requirement for a significant degree of frontal and/or 
temporal lobe atrophy remains neuroanatomically heterogeneous in the population we have 
studied. Our results align with two smaller studies reporting consistent differences in 
patterns of degeneration across cortical areas in patients diagnosed as having bvFTD by 
consensus criteria (Ranasinghe et al., 2016; Whitwell et al., 2009). This consistency 
between studies is preserved despite sampling of different subsets of regional volumes and 
utilisation of different statistical classifications. The frontal-dominant, temporal-dominant 
and fronto-temporo-parietal groups are comparable with the same anatomical sub-types 
identified by Whitwell and colleagues (2009). Ranasinghe and colleagues (2016)  designate 
essentially the same anatomical subtypes in terms of a theoretical construct as the salience-
network-frontal subtype (i.e., frontal-dominant), the semantic appraisal-network sub-type 
(i.e., temporal dominant) and salience-network-frontotemporal (i.e., fronto-temporo-
parietal) subtype. Their sub-cortical subtype parallels our sub-lobar subtype. Although it is 
possible that the sub-lobar subtype might represent an earlier stage of the disease, 
Ranasinghe and colleagues have argued that it represents a true bvFTD subtype which 
progresses more slowly.  We found no global cognitive, functional or behaviour differences 
which might have been expected if it represented an earlier stage of the disease. Our data 
therefore support the suggestion of Ranasinghe and colleagues that this is indeed a distinct 
subtype, and that its prevalence is comparable to that of the frontal- and temporal-dominant 
subtypes.
Heterogeneity at the cortical level is associated to only a limited extent with distinct 
behavioural, functional and cognitive features. The frontal-dominant subtype is 
characterised by greater global impairment on both the FRS and FAQ scales. It is notable 
that the frontal-dominant subtype is the most severely affected in terms of behavioural 
symptoms such as lack of appropriate social response, apathy and disinterest, as well as 
disinhibition and problematic positive behaviours. In other words, in contrast to the overall 
importance of highly connected networks in defining the bvFTD syndrome, the frontal lobe 
remains particularly important for regulation of behaviour. By contrast, cognitive deficits 
segregate as expected, with the temporal-dominant form associated particularly with 
semantic memory and language semantics, and a stronger association between frontal-
dominant atrophy and impairment in letter fluency.
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Independently of the sub-type, a summary metric variable for the core features (the 
first unrotated factor), was found to have a highly significant statistical association with 
cognitive impairment, particularly with ACE-R, and with functional impairment as 
measured by the FAQ scale.  After adjusting for the core factor, there was no residual 
association with subtype. On the other hand, the behavioural subscale derived from the 
FRS retained a significant association with anatomical subtype after taking account of the 
core factor variable.  This may explain the possible latent nature of the pure sub-lobar 
subtype (Ranasinghe et al., 2016) in which prominent behavioural deficits may not be 
demonstrated.  
This mapping of imaging features to clinical features should be viewed in the context 
of the inclusion criteria of this study, namely the requirement for presence of brain atrophy 
in frontal and/or temporal lobes scoring two or more on a scale proposed by Kipps (Kipps 
et al., 2008).  That is subjects with little or no frontal and/or temporal atrophy and who 
fulfilled all other criteria for bvFTD were not included.  The results of the present analysis 
suggest that the diagnostic utility of MRI in the differentiation of bvFTD from healthy 
controls and other dementias may be best served by examining the core features with or 
without the frontal and temporal lobes.  A recent study reports that a data driven approach 
for discriminating between bvFTD patients and controls showed good discriminatory 
performance without a priori knowledge of any potential structure within the data (Manera 
et al., 2019).  It remains to be determined how a prior knowledge of the core features we 
have described could improve the discrimination.  More importantly, it remains to be 
determined how incorporating a core feature metric assists with the more pertinent clinical 
question which is to discriminate between bvFTD and other dementias.
Limitations and conclusions
There are limitations to the inferences which can be drawn from the present study. 
Although it is based on a large sample, it is possible that still greater power is required to 
define the subtle clinical features of the subtypes. Similarly, the clinical scales we have 
used to interrogate the bvFTD phenotype may not be sufficiently discriminatory, and more 
refined neuropsychological measures may characterise the clinical features of the subtypes 
with greater subtlety. A further limitation is that we have used patterns of atrophy on MRI 
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as the sole investigative tool for analysing the brain abnormalities of bvFTD. Although this 
has the advantages of a wide applicability and standardisation, metrics based on functional 
MRI that may be able to define abnormalities in the underlying connectome were not 
available in the present study. Again, there is a trade-off between the feasibility of more 
refined approaches and study size/cost considerations.  
Notwithstanding these limitations, a useful general picture that emerges from our 
study is that the MRI abnormalities in the bvFTD syndrome can be characterised at two 
neuroanatomical levels. The core of the syndrome appears to depend on a common pattern 
of degeneration in which basal and limbic lobes are disproportionately represented. Some, 
but not all of these, have been identified previously as brain structural and functional 
network hubs. In addition, the neuroanatomical heterogeneity at the cortical level, which is 
robust and reproducible across studies, appears to have limited explanatory power in 
accounting for cognitive, functional and behavioural heterogeneity. Our results are 
consistent with the idea that bvFTD is characterised by a core disturbance within basal, 
limbic and frontal networks required for integration of cognition, function and behaviour. 
This core disturbance at the level of integration may help to understand both the 
inappropriate conduct that families find distressing and the higher rates of socially 
inappropriate behaviour and criminality in bvFTD than in other comparable 
neurodegenerative disorders (Liljegren et al., 2019). There appears to be a dissociation 
between the cognitive understanding of actions and their consequences   as matters of fact, 
and the capacity for an appropriate evaluation of their personal and societal implications 
(Mendez, 2010; Sfera et al., 2014). The loss of insight that characterises the condition could 
be understood as resulting from pathology affecting particularly the central integrative 
systems that enable segregated functional regions of the brain to interact and communicate.
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Figure 1. Analysis pipeline.  A schematic of the analysis pipeline including Free Surfer 
Region of Interest (ROI) analysis, hierarchical clustering and Voxel-Based Morphometry 
(VBM). Note the involvement of two study groups, healthy control and behavoural variant 
frontotemporal dementia (bvFTD), in different steps. Clasification of bvFTD subjects into 
four clusters was done on 68 cortical regions of interest (ROIs) extracted using Free Surfer.  
Each cluster was then compared with the healthy control group using VBM (blue box) and 
anatomical bvFTD sub-types were identified from this analysis based on cortical atrophy 
(yellow areas on the cortical surface). The core regions are common to all four sub-types. 
Figure 2. Surface maps for four sub-types. (A) Fronto-temporo-parietal; (B) temporal-
dominant; (C) frontal-dominant; and (D) sub-lobar. bvFTD individuals clustered based on 
differences in the 68 regional volumes. Yellow areas represent significant volume loss in 
each bvFTD cluster/sub-type (sagittal and medial views) based on pair-wise comparisons 
with the healthy control group. 
Figure 3. Surface maps for differences between sub-types. (A) TDP > FTP; (B) FD > 
FTP; (C) TD > FD; (D) FD > TD; (E) FTP > SL; and (F) FD > SL. Pair-wise differences 
between the four identified bvFTD clusters/groups mapped onto the cortical surface. 
Hot/cold colours indicate t-test statistics used for the voxel-wise comparisons. Hot colours 
indicate ’more’ atrophy (as indicated in each panel by an inequality sign). 
Figure 4. Behavioural scores by sub-type. (A) Frontotemporal dementia rating score; (B) 
functional activities questionnaire; (C) behavioural symptoms; (D) disinhibition; (E) 
apathy/disinterest; and (F) problematic behaviours. Box-plots with individual data points 
superimposed for behavioural and functional sub-scores for bvFTD sub-types.
Figure 5. Cognitive scores by sub-type. (A) Attention; (B) perceptual abilities; (C) 
semantic memory; (D) letter fluency; (E) language phonemics; and (F) language 
semantics. Box-plots with individual data points superimposed for cognitive sub-scores for 
bvFTD sub-types.
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Table 1. Demographic and clinical data on bvFTD and healthy elderly subjects. 









Age (Years) 63 (7) 42 – 70 63 (7) 63 (7)
Education (Years) 12 (4) 4 – 23 12 (3) 12 (4)
Handedness (R/L;A) 195/21;2 (R/L;A) 123/13;2 72/8;0
eTIV (cm3) 1500 (220) 897 – 3077 1600 (220)** 1400 (150)
BF (TBV/eTIV) 0.67 (0.06) 0.37 – 0.94 0.67 (0.06) 0.68 (0.05)
MMSE (0 – 30) 24.5 (3.9) 11 – 30 25.4 (3.5)** 22.9 (4.0)
ACE-R (0 – 100) 68.5 (16.0) 17 – 99 72 (16)** 62 (14)
Attention (0 – 8) 3.9 (1.5) 0 – 8 4.4 (1.2)** 3.2 (1.7)
Orientation (0 – 10) 8.2 (1.9) 1 – 10 8.5 (1.8)** 7.7 (2.1)
Category fluency (0 – 7) 2.8 (1.9) 0 – 7 3.2 (2.0)** 1.8 (1.6)
Letter fluency (0 – 7) 2.8 (1.9) 0 – 7 3.1 (2.1)** 2.2 (1.7)
Language – phonemics (0 – 2) 1.5 (0.7) 0 – 2 1.6 (0.7) 1.4 (0.8)
Language – semantics (0 – 17) 12.7 (4.4) 1 – 28 13.2 (4.7)** 11.8 (3.8)
Language – structure (0 – 7) 6.2 (1.2) 2 – 11 6.2 (1.2) 6.0 (1.0)
Episodic memory (0 – 22) 12.8 (5.0) 0 – 22 13.3 (4.7) 12.1 (5.6)
Semantic memory (0 – 4) 2.4 (1.3) 0 – 4 2.6 (1.3)** 2.1 (1.2)
Perceptual abilities (0 – 8) 7.4 (1.2) 2 – 8 7.6 (0.9) 7.0 (1.5)
Praxis (0 – 8) 5.4 (2.3) 0 – 8 6.0 (2.0)** 2.4 (0.3)
FRS (-6.66 – 5.39) -0.42 (1.45) -3.80 – 5.39 -0.30 (1.4) -0.62 (1.4)
ADL (%) 0.53 (0.25) 0 – 1 0.55 (0.26)* 0.48 (0.24)
Behavioural symptoms (%) 0.41 (0.22) 0 – 1 0.40 (0.22) 0.42 (0.23)
Cognition (%) 0.36 (0.38) 0 – 1 0.38 (0.40) 0.34 (0.37)
Apathy/disinterest (%) 0.38 (0.26) 0 – 1 0.39 (0.25) 0.37 (0.28)
Disinhibition (%) 0.39 (0.38) 0 – 1 0.35 (0.36)* 0.47 (0.39)
Eating behaviours (%) 0.60 (0.30) 0 – 1 0.60 (0.28) 0.63 (0.29)
Positive/problematic behaviours 0.44 (0.27) 0 – 1 0.42 (0.27) 0.47 (0.27)
FAQ (0 – 30) 13.8 (7.2) 0 – 30 13.2 (7.1) 14.9 (7.2)
UPDRS (0 – 100) (%) 58 (11) 0 – 99 57 (10) 59 (13)









Age (Years) 69 (2) 67-77 69 (2) 69 (2)
Education (Years) 11 (2) 9-19 11 (2) 11 (2)
MMSE (0 – 30) 28.9 (1.2) 26 – 30 28.9 (1.1) 28.9 (1.2)
Significant differences between males and females: *p < 0.05, **p < 0.01. 
Abbreviations: R = Right; L = Left; A = Ambidextrous; eTIV = estimated Total Intra-cranial Volume; 
TBV = Total Brain Volume; BF = Brain Fraction; ACE-R = Addenbrooke’s Cognitive Examination 
Revised; MMSE = Mini-Mental State Examination; FRS = Frontotemporal Dementia Rating Scale; 
ADL = Activities of Daily Living; FAQ = Functional Activities Questionnaire; UPDRS = Unified 
Parkinson’s Disease Rating Scale. 
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Table 2. Cortical regions with differences in the brain matter volume common to all four 
identified bvFTD sub-types. The group-wise differences at the whole brain level were 
classified by voxel-based-morphometry (VBM) against the healthy elderly group using 
maximum of the t-tests statistics (separated by more than 1 mm) within a cluster and then 
labelled according to Automated Anatomical Labelling (AAL) implemented in SPM.  
Region Sub-type (N)
FTP (82) FD (41) SL (39) TD (51)
Limbic lobe
Insula ● ● ● ●
Cingulate_Ant ● ● ● ●
Hippocampus ● ● ● ●
ParaHippocampal ● ● ● ●
Temporal_Pole_Sup ● ● ● ●
Sub-cortical grey nuclei
Amygdala ● ● ● ●
Caudate ● ● ● ●
Pallidum ● ● ● ●
Thalamus ● ● ● ●
Central region
Precentral ● ● ● ●
Frontal lobe
Frontal_Inf_Orb ● ● ● ●
Supp_Motor_Area ● ● ● ●
Olfactory ● ● ● ●
Frontal_Sup_Medial ● ● ● ●
Rectus ● ● ● ●
Temporal lobe
Temporal_Mid ● ● ● ●
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Table 3. Cortical regions with differences in the brain matter volume specific to either of four 
identified bvFTD sub-types (black-filled circles). The group-wise differences at the whole 
brain level were classified by voxel-based-morphometry (VBM) against the healthy elderly 
group using maximum of the t-tests statistics (separated by more than 1mm) within a cluster 
and then labelled according to Automated Anatomical Labelling (AAL) implemented in SPM.  
Region Sub-type (N)
FTP (82) FD (41) SL (39) TD (51)
Limbic lobe
Temporal Pole Mid L ○ ○ ○ ●
Sub-cortical grey nuclei
Putamen ○ ● ● ●
Central region
Rolandic Oper ● ○ ○ ○
Postcentral ○ ● ○ ●
Frontal lobe
Frontal Sup ● ● ● ○
Frontal Mid ● ● ● ○
Frontal Inf Oper ● ● ● ○
Frontal Inf Tri ● ● ● ○
Frontal Med Orb ○ ● ○ ○
OFCant ○ ● ● ○
Temporal lobe
Heschl L ○ ○ ● ○
Temporal Sup ○ ○ ● ○
Temporal Inf ○ ○ ● ○
Parietal lobe
Parietal Sup ○ ○ ○ ●
Parietal Inf ● ● ○ ●
SupraMarginal ○ ● ○ ●
Angular ○ ● ○ ●
Precuneus ● ○ ● ○
Paracental Lobule ○ ○ ○ ○
Occipital lobe
Occipital Sup ○ ● ○ ○
Occipital Mid ○ ○ ○ ●
Occipital Inf ○ ○ ○ ○
Fusiform ○ ● ● ●
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Table 4. Behavioural and cognitive variables used in the study in four bvFTD subtypes and corresponding demographic data. 
Cognitive      
      
ACE-R 68 (17) 68 (17) 70 (18) 68 (13) 0.82 
Attention 3.8 (1.5) 3.6 (1.6) b 3.8 (1.5) 4.5 (1.2) 0.02 
Orientation 8.2 (2.0) 7.7 (2.2) 8.3 (2.0) 8.5 (1.7) 0.23 
Category fluency 2.8 (2.1) 2.3 (2.0) 3.0 (2.1) 2.6 (1.7) 0.36 
Letter fluency 2.8 (2.1) 2.2 (1.8) a 2.8 (2.1) 3.4 (1.8) 0.038 
Episodic memory 13.0 (5.2) 13.4 (5.4) 12.5 (4.7) 12.6 (4.7) 0.84 
Semantic memory 2.5 (1.2) 2.7 (1.2) 2.9 (1.2) 1.8 (1.3)d,a,e <0.001 
Perceptual abilities 7.1 (1.2) d 7.0 (1.0) a 7.5 (1.3) 7.8 (0.7) 0.006 
Praxis 5.0 (2.4) 5.5 (2.1) 5.4 (2.6) 6.0 (2.0) 0.08 
Language–phonemics 1.3 (0.8) c 1.7 (0.6) 1.6 (0.6) 1.6 (0.7) 0.013 
Language–structure 6.2 (1.2) 6.0 (1.1) 6.4 (0.8) 6.1 (1.2) 0.55 
Language–semantics 13.8 (3.9) 13.7 (3.6) 14.2 (2.6) 8.9 (4.7)d,a,e <0.001 
      
MMSE 24.5 (3.7) 23.2 (4.1) 24.5 (4.3) 25.5 (3.5) 0.09 
      
Clinical Scores Sub-type (N)
FTP (N=82) FD (N=41) SL (N=39) TD (N=51) p -value
Behavioural and Functional 
      
FRS -0.45 (1.37) -1.10 (1.43) a,b -0.01 (1.1) -0.10 (1.65) 0.02 
Behavioural symptoms 0.42 (0.21) 0.31 (0.19) c,b 0.51 (0.19) 0.41 (0.24) 0.001 
Cognition 0.36 (0.36) 0.33 (0.39) 0.33 (0.31) 0.43 (0.36) 0.54 
ADL 0.52 (0.23) 0.41 (0.23) a,b 0.59 (0.22) 0.58 (0.27) 0.003 
Apathy/disinterest 0.36 (0.26)  0.25 (0.20) a,b 0.47 (0.24) 0.48 (0.27) d 0.001 
Eating behaviours 0.63 (0.29) 0.55 (0.27) 0.68 (0.26) 0.54 (0.27) 0.08 
Disinhibition 0.42 (0.40) 0.22 (0.30) c,b 0.56 (0.34) 0.35 (0.35) e 0.004 
Problem behaviours 0.47 (0.24)  0.37 (0.25) b 0.55 (0.24) 0.35 (0.27) d, e 0.001 
      
FAQ 13.6 (7.0) 16.6 (7.8) d,b 12.0 (6.1) 12.5 (7.8) 0.02 
      
UPDRS 59 (8) 57 (16) 58 (11) 58 (9) 0.56 
      
Page 32 of 41
https://mc.manuscriptcentral.com/braincom










































































Significant (p < 0.05) differences between the bvFTD subtypes in behavioural and cognitive sub-scores. FTP = frontotemporoparietal; TD = temporal-dominant; FD = frontal-
dominant; SL = sub-lobar; FRS = Frontotemporal Dementia Rating Scale; ACE-R = Addenbrooke’s Cognitive Examination Revised; MMSE = Mini-Mental State Examination; 
FAQ = Functional Activities Questionnaire; UPDRS = Unified Parkinson’s Disease Rating Scale; AChEI/Mem = acetylcholinesterase inhibitor and/or memantine (1 = taking 
medication/s); M = Male; F = Female. 
a  differences between FD and TD d  differences between TD and FTP
b  differences between FD and SL e  differences between TD and SL
c  differences between FD and FTP f p-value reported for the Pearson’s Chi-square test. 
Clinical Scores FTP (N=82) FD (N=41) SL (N=39) TD (N=51) p -value
AChEI/Mem 64/18 34/7 29/10 44/7 0.48
Demographics
Age 63.5 (7.5) 63.3 (7.4) 63.4 (7.3) 62.6 (7.8) 0.33 
Education 14.6 (6.0) 16.0 (6.0) 15.7 (6.6) 15.0 (6.0) 0.30 
Gender (M/F) 53/29 21/20 25/14 37/14 
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Table 5. Statistical analysis: Correlation between cognitive, behaviour and functional scores 
and the regional core factor score.  The GLM output is shown for the association between the 
cognitive, behavioural and functional scores and the regional factor score after adjusting for 
sex and subtype age and head size.
Clinical 
Scores
     Core Factor             Core Factor       Group
a Corr. b p c F b p d Post hoc c F b p d Post hoc 
ACE-R 0.44 <0.001 22.7 <0.001 FTP/FD 1.43 0.24
FAQ -0.22 0.001 5.04 0.03 TD/FD 1.82 0.15
MMSE 0.34 <0.001 9.80 0.02 TD/FD 0.51 0.68
Behaviour 0.14 0.038 3.24 0.07 3.19 0.03 FD/SL
UPDRS -0.050 0.47 0.10 0.75 0.69 0.56
a Pearson correlation (Corr.) was determined for the core factor; significant values in bold.
b Two-tailed p value.
c A GLM used to analyse the output by core factor and by group; significant values in bold.
d Post-hoc analysis for group differences significant at p < 0.05
Abbreviations: ACE-R = Addenbrooke’s Cognitive Examination Revised; FAQ = Functional Activities 
Questionnaire; FTP = frontotemporoparietal; FD = frontal-dominant; GLM = General Linear Model; MMSE = 
Mini-Mental State Examination; Behaviour = Behavioural sub-score from Frontotemporal Dementia Rating 
Scale; SL = sub-lobar; TD = temporal-dominant; UPDRS = Unified Parkinson’s Disease Rating Scale.
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Degeneration of basal and limbic networks is a core feature of
behavioural variant frontotemporal dementia
Vesna Vuksanović, Roger T. Staff, Suzannah Morson, Trevor Ahearn, Luc Bracoud, Alison D. 
Murray, Peter Bentham, Christopher M. Kipps, Charles R. Harrington and Claude M. Wischik
Abbreviated summary
Using trial baseline MRI scans from 213 behavioural variant frontotemoporal dementia 
patients, Vuksanovic et al. report that the four known cortical atrophy subtypes all share 
degeneration in core basal, limbic and frontal network hubs that correlates with cognitive and 
functional impairment irrespective of subtype.
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